Navigation Links
Sunpeaks Ventures Inks Sponsorship and Marketing Agreement with Major Sports Team, Clotamin To Be Sold at Walgreens Locations Throughout Oregon and Southern Washington
Date:4/6/2012

SILVER SPRING, Md., April 6, 2012 /PRNewswire/ -- Sunpeaks Ventures, Inc. (OTCBB: SNPK) (PINKSHEETS: SNPK) (the "Company" or "Sunpeaks Ventures") and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS") are pleased to announce that HDS has entered into a sponsorship agreement ("Agreement") with a major pro sports team ("Team") for the marketing of Clotamin, including advertising, media, and promotional elements. The Agreement is part of new marketing initiatives to launch Clotamin in 79 Walgreens stores in Oregon and southern Washington.

Under terms of the Agreement, HDS, in conjunction with Walgreens, will have the right to make use of the Team name and logo in connection with all advertising retail displays to be placed at Walgreens locations in the Portland, Oregon, metropolitan area. HDS and Walgreens will also receive digital advertising space in the Rose Garden Arena on the lower ring and corners of the scoreboard and on all televisions menu boards at the arena during all Team home games. Clotamin advertising will also be displayed on the Team websites, subject to approval.

"We continue to grow awareness and acceptance of Clotamin nationwide through quality advertising, strong endorsements, and strategic sponsorships," stated Mackie A. Barch, CEO of Sunpeaks Ventures. "Launching in Oregon with pharmacy powerhouse Walgreens and a highly-recognizable pro sports team focused marketing campaign will allow us to quickly introduce the benefits of Clotamin to their many loyal customers and fans."

In addition, the Team has also agreed to provide promotional elements to support a no-purchase necessary, enter-to-win sweepstakes sponsored by HDS, Walgreens, and the Team, in connection with the advertising retail displays to be placed at Walgreens locations. Promotional elements may include, but are not limited to, tickets to Team home games, team clothing or merchandise, gift bags containing Team souvenirs, post-game events, tickets to non-Team events at the Rose Garden Arena, and gift cards.

Established in 1901, Walgreens is a national leader at developing and implementing innovative pharmacy practices from online sales to advanced Medical Therapy Management (MTM). Walgreens has been included for 19 consecutive years on Fortune Magazine's "World's Most Admired Companies" list. Walgreens has over 8350 stores throughout the United States.

About Sunpeaks Ventures, Inc.

Sunpeaks Ventures, Inc. and its wholly owned subsidiary Healthcare Distribution Specialists, LLC ("HDS"), is a nationally focused, value-added distributor of specialty drugs and over-the-counter ("OTC") branded multivitamins to the healthcare provider market. HDS also owns and markets Clotamin®, a specialized over-the-counter multivitamin product designed exclusively for use by patients also on Warfarin®, a popular blood thinner that has a long list of known adverse drug and food interactions.

For additional information, please visit www.sunpeaksventures.com.

Contact: Financial Insights 888-248-8491 or info@sunpeaksventures.com

Safe Harbor Statement

Information in this document constitute forward-looking statements or statements which may be deemed or construed to be forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "forecast", "anticipate", "estimate", "project", "intend", "expect", "should", "believe", and similar expressions are intended to identify forward-looking statements. These forward-looking statements involve, and are subject to known and unknown risks, uncertainties and other factors which could cause Sunpeaks Ventures' actual results, performance (financial or operating) or achievements to differ from the future results, performance (financial or operating) or achievements expressed or implied by such forward-looking statements. The risks, uncertainties and other factors are more fully discussed in Sunpeaks Ventures' filings with the U.S. Securities and Exchange Commission. All forward-looking statements attributable to Sunpeaks Ventures herein are expressly qualified in their entirety by the above-mentioned cautionary statement. Sunpeaks Ventures disclaims any obligation to update forward-looking statements contained in this estimate, except as may be required by law.


'/>"/>
SOURCE Sunpeaks Ventures, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Sunpeaks Ventures Announces Agreement with Asian American Convenience Store Association Partners to Sell Clotamin in 1,200 Stores
2. Sunpeaks Ventures Announces Agreement with Albeck Financial Services
3. Sunpeaks Ventures Announces Clotamin to Be Sold at Winn-Dixie Locations in South Florida
4. Sunpeaks Ventures Announces Clotamin to be Sold at Bravo Supermarkets in South Florida
5. Sunpeaks Ventures to Participate in ECRM Conference and Expo
6. Sunpeaks Ventures Announces Clotamin to be Sold at Navarro Discount Pharmacies
7. Sunpeaks Ventures Announces Clotamin available on Walgreens.com
8. Sunpeaks Ventures Enters $45 Billion Specialty Drug Distribution Sector
9. Sunpeaks Ventures Completes Acquisition of Healthcare Distribution Specialists LLC
10. GMH Ventures Acquires Majority Ownership in Dynamic Healthcare Services, Leading Provider of Medical Equipment and Respiratory Therapy Products and Services
11. Vivo Ventures Closes $375 Million 7th Fund to Invest in Healthcare in the U.S. and Greater China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... 2016   Pulmatrix, Inc ., (NASDAQ: ... drugs, announced today that it was added to the ... its comprehensive set of U.S. and global equity indexes ... important milestone for Pulmatrix," said Chief Executive Officer ... our progress in developing drugs for crucial unmet medical ...
(Date:6/24/2016)... , June 24, 2016  Arkis BioSciences, ... less invasive and more durable cerebrospinal fluid treatments, ... funding.  The Series-A funding is led by Innova ... Fund, and other private investors.  Arkis, new financing ... instrumentation and the market release of its in-licensed ...
(Date:6/23/2016)... 23, 2016 Research and Markets has ... - Forecast to 2022" report to their offering. ... for the patients with kidney failure, it replaces the function ... the patient,s blood and thus the treatment helps to keep ... in balance. Increasing number of ESRD patients ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... ... of Bruton Memorial Library on June 21 due to a possible lice infestation, as reported ... head lice: the parasite’s ability to live away from a human host, and to infest ... in the event that lice have simply gotten out of control. , As lice are ...
(Date:6/25/2016)... ... June 25, 2016 , ... On Friday, June 10, ... Bronze Wellness at Work award to iHire in recognition of their exemplary accomplishments in ... the 7th annual Maryland Workplace Health & Wellness Symposium at the BWI Marriott in ...
(Date:6/24/2016)... CA (PRWEB) , ... June 24, 2016 , ... Marcy was in a crisis. Her ... would lash out at his family verbally and physically. , “When something upset him, he ... he would use it. He would throw rocks at my other children and say he ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and ... that call for a minimum wage raise to $12 an hour by 2020 and then ... will restore the lost value of the minimum wage, assure the wage floor does not ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... feeding the Frederick area economy by obtaining investment capital for emerging technology companies. ... 2½ years that have already resulted in more than a million dollars of ...
Breaking Medicine News(10 mins):